MAPT and Alzheimer disease: Tau and CX3CL1 interact competitively with CX3CR1, and the expression level of CX3CL1 is reduced in the AD brain, so CX3CR1 directly binds to Tau and promotes its internalization and uptake (Chidambaram et al., 2020).